BOSTON--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced it has raised an oversubscribed $5.2 million seed ...
Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma “It’s an honor to join Predicta and our strong team of leading ...
DALLAS--(BUSINESS WIRE)--What keeps you up at night? Here at Predicta (www.predicta.com/blog), a question weighed heavily on our minds that needed to be solved before ...
CAMBRIDGE, Mass., April 30, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its ...
The Brazilian media group Grupo RBS has taken a minority share in Predicta, the companies announced today. As we reported, Predicta is one of Brazil’s most innovative companies. With a staff of 130 ...
Predicta is expanding to the US and opening offices in Silicon Valley, the decade-old Brazilian B2B tech company announced today. As you may remember, it first announced these plans last December in ...
CAMBRIDGE, Mass., October 01, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback